Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 23,678,798	$ 18,795,517	$ 15,430,383
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,533,564	3,297,289	3,544,470
Abandoned patents or software written off		88,796	413,589
Provision for bad debts	477,577	(201,949)	2,475,032
Deferred income tax benefit - net	(4,969,669)	(4,647,767)	(2,756,517)
Gain on acquisition		(192,999)
Compensatory element of stock issuances	2,397,276	$ 2,006	53,200
Gain on extinguishment of debt			(394,797)
Stock issued for costs and expenses	$ 2,239,302		109,950
Stock option exercised	1,680	1,755
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivables	$ (5,899,611)	$ (3,557,507)	(4,258,147)
Notes receivable	11,511	28,280	135,592
Costs and estimated earnings in excess of Billings on uncompleted contracts	(736,061)	681,660	78,149
Inventories	450,038	117,549	251,687
Prepaid expenses and other current assets	(513,507)	72,718	67,192
Other assets	254,721	18,054	41,125
Increase (decrease) in operating liabilities, net:
Accounts payable	168,733	(527,957)	(699,555)
Other current liabilities	(3,660,895)	3,065,673	(1,041,214)
Customer advances	(410,855)	(739,074)	11,000
Billings in excess of costs and estimated earnings on uncompleted contracts	(206,623)	64,406
Other Liabilities	8,783	242,798	(190,561)
Due to related party medical practices	(17,498)	8,121	2,339
NET CASH PROVIDED BY OPERATING ACTIVITIES	16,807,264	16,617,369	13,272,917
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(2,851,158)	(712,216)	(131,308)
Cost of acquisition	(1,312,769)	(4,223,567)
Cost of patents	(155,156)	(113,072)	(139,534)
NET CASH USED IN INVESTING ACTIVITIES	(4,319,083)	(5,048,855)	(270,842)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of borrowings and capital lease obligations	(3,990,078)	(3,682,519)	(2,788,401)
Repayment of notes receivable from employee stockholders	7,333	7,616	7,333
Distributions to noncontrolling interests	(6,981,953)	(5,909,100)	(4,627,851)
Redemption of noncontroling Interests		(2,905,000)	(1,125,000)
Proceeds received from acquisition -net	87,829
Buyout of noncontroling Interest			(4,971,094)
NET CASH USED IN FINANCING ACTIVITIES	(10,876,869)	(12,489,003)	(13,505,013)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	1,611,312	(920,489)	(502,938)
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	8,528,309	9,448,798	9,951,736
CASH AND CASH EQUIVALENTS - END OF YEAR	$ 10,139,621	$ 8,528,309	$ 9,448,798